Blood-Vessels 发表于 2025-3-25 05:35:45

http://reply.papertrans.cn/1/77/7678/7678-21.png

新奇 发表于 2025-3-25 09:27:56

Submitted on: 29 June 2006.
Revised on: 09 September 2006.
Accepted on: 02 October 2006.

___________________DRUGS IN R&D---SPRINGER INT PUBL AG

BLAND 发表于 2025-3-25 12:16:56

Submitted on: 25 March 2019.
Revised on: 15 April 2019.
Accepted on: 01 May 2019.

___________________DRUGS IN R&D---SPRINGER INT PUBL AG

高度 发表于 2025-3-25 16:51:53

Submitted on: 15 October 2006.
Revised on: 16 December 2006.
Accepted on: 04 January 2007.

___________________DRUGS IN R&D---SPRINGER INT PUBL AG

endarterectomy 发表于 2025-3-25 22:27:13

Submitted on: 06 May 2022.
Revised on: 20 August 2022.
Accepted on: 22 September 2022.

___________________DRUGS IN R&D---SPRINGER INT PUBL AG

ELATE 发表于 2025-3-26 03:20:34

Submitted on: 11 October 2004.
Revised on: 27 November 2004.
Accepted on: 15 December 2004.

___________________DRUGS IN R&D---SPRINGER INT PUBL AG

Transfusion 发表于 2025-3-26 06:21:55

http://reply.papertrans.cn/1/77/7678/7678-27.png

包裹 发表于 2025-3-26 12:33:29

http://reply.papertrans.cn/1/77/7678/7678-28.png

instructive 发表于 2025-3-26 16:42:58

http://reply.papertrans.cn/1/77/7678/7678-29.png

Allure 发表于 2025-3-26 18:24:11

http://reply.papertrans.cn/1/77/7678/7678-30.png
页: 1 2 [3] 4
查看完整版本: SCIE期刊DRUGS IN R&D 2024/2025影响因子:2.237 (DRUGS R&D) (1174-5886). (PHARMACOLOGY & PHARMACY)(药理学与药学)Science Citation Index